Takashi Kurosaki
Sayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Immune-related gene expression profiling and alectinib efficacy for patients with ALK-Rearranged non-small cell lung cancer: exploratory analysis of a prospective observational study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 05, 2025
Daily low-dose carboplatin or weekly carboplatin plus nab-paclitaxel for concurrent chemoradiotherapy in older patients with locally advanced non-small cell lung cancer (JCOG1914): A randomized phase 3 trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 18, 2025
Zongertinib, a Novel HER2 Tyrosine Kinase Inhibitor, Maintains an Anticancer Activity for Trastuzumab Deruxtecan-Resistant Cancers Harboring HER2-Overexpression.
Journal: International journal of molecular sciences
Published: September 29, 2025
Impact of B7-H3 and DLL3 expression on the efficacy of PD-L1 blockade therapy in extensive-stage small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 03, 2025
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 22, 2024
Detection of Overlooked Rare EGFR Mutations in Non-small Cell Lung Cancer Using Multigene Testing.
Journal: Thoracic cancer
Published: September 24, 2024
Malignant transformation of an ovarian mature teratoma diagnosed 17 years ago: a case report and literature review of treatment with immune checkpoint inhibitors.
Journal: International cancer conference journal
Published: July 11, 2024
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study.
Journal: Frontiers in immunology
Published: October 21, 2023
Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockade.
Journal: The Journal of clinical investigation
Published: December 22, 2022
Gastroparesis as a significant gastrointestinal adverse event during intensive chemotherapy for solid caner: a case report.
Journal: Translational cancer research
Published: December 19, 2021
Handling of Japanese Subgroup Data in Global Clinical Trials and Its Clinical Significance-In Terms of Systemic Therapies for Advanced Lung Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: November 19, 2021
Last Updated: 09/26/2026